Form 4: NV5 Global Executive O'Brien Reports Acquisition of 10,000 Shares

Sentiment:

SEC Form 4 Filing


MaryJo O'Brien, Executive VP, Chief Admin & Secretary of NV5 Global, Inc., reports acquiring 10,000 shares of common stock on March 10, 2025, as part of the company's 2023 Equity Incentive Plan.

Summary

  • MaryJo O'Brien, an executive at NV5 Global, Inc., filed a Form 4 with the SEC.
  • The filing reports the acquisition of 10,000 shares of NV5 Global common stock on March 10, 2025.
  • These shares were granted in connection with the NV5 Global Inc. 2023 Equity Incentive Plan.
  • The shares are a restricted stock award and are forfeitable until vested.
  • Vesting occurs three years from the grant date, March 10, 2025.
  • Following the transaction, O'Brien beneficially owns 263,621 shares of NV5 Global common stock.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a routine filing related to an equity incentive plan, which is generally viewed as a positive for aligning management and shareholder interests, but it doesn't contain any groundbreaking news.

Positives

  • The equity incentive plan aligns the interests of the executive with those of the shareholders.
  • The vesting schedule encourages long-term commitment from the executive.

Future Outlook

The document does not contain any specific forward-looking statements or guidance.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. This filing indicates that a key executive received shares as part of an equity incentive plan, which is a common practice in publicly traded companies to incentivize and retain talent.

Comparison to Industry Standards

  • Equity incentive plans are a standard practice among publicly traded companies to align management's interests with those of shareholders.
  • Vesting schedules, such as the three-year vesting period in this case, are typical for restricted stock awards.
  • The size of the equity grant should be compared to grants given to executives at comparible companies to determine if it is above or below industry standards.

Stakeholder Impact

  • The transaction could have a slightly positive impact on shareholders by aligning management's interests with the company's long-term success.

Key Dates

DateDescription
03/10/2025Date of transaction (acquisition of shares)
03/10/2028Vesting date of restricted stock award (three years from grant date)
03/12/2025Date of signature on the Form 4 filing

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.